Nova University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02848417
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal

Active Ingredients

Drugs in Phase 4 Trials (1)

bacille calmette-guerin (1 trial)

Drugs in Phase 2 Trials (2)

curcumin (1 trial)

glutathione (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Persian Gulf Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3